Manhattan Scientifics (MHTX) Stock Price, News & Analysis

Company Overview

Manhattan Scientifics, Inc. (OTCMKTS:MHTX) is a development-stage company focused on creating and commercializing advanced nanotechnology-enabled products and services. The company’s core operations span research, development and licensing of proprietary technologies in the fields of biomedical coatings, pharmaceutical delivery systems and diagnostic imaging. Manhattan Scientifics leverages a multidisciplinary approach to translate laboratory innovations into scalable commercial solutions for healthcare, defense, and industrial applications.

Among its primary offerings, Manhattan Scientifics has advanced biocompatible surface treatments designed to improve the performance and longevity of medical implants and surgical instruments. These coatings employ plasma-deposition techniques to create nanoscale films that resist corrosion, inhibit bacterial growth and enhance tissue integration. In addition, the company has pursued novel drug-delivery vehicles that utilize nanocarriers to achieve controlled release profiles, targeting therapeutic agents to specific cells or tissues while minimizing systemic side effects.

Founded in the early 1990s, Manhattan Scientifics has undergone several strategic restructurings and asset acquisitions aimed at sharpening its focus on high-value nanotech platforms. The organization operates through a network of wholly owned subsidiaries and joint-venture partnerships in North America and Europe. Its management team combines expertise in materials science, pharmaceutical development and regulatory affairs, while its board of directors includes seasoned professionals from the biotech and engineering sectors.

Manhattan Scientifics serves a global customer base, collaborating with academic institutions, contract research organizations and original equipment manufacturers to advance its product pipeline. The company continues to expand its intellectual property portfolio and pursue regulatory clearances, with the goal of bringing next-generation nanotechnology solutions to market across the medical device, life sciences and industrial markets.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 275 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MHTX Stock Analysis - Frequently Asked Questions

How were Manhattan Scientifics' earnings last quarter?

Manhattan Scientifics Inc. (OTCMKTS:MHTX) released its quarterly earnings data on Monday, August, 20th. The technology company reported $0.00 EPS for the quarter.

How do I buy shares of Manhattan Scientifics?

Shares of MHTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Manhattan Scientifics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Manhattan Scientifics investors own include Avino Silver & Gold Mines (ASM), Sierra Wireless (SW), Advanced Micro Devices (AMD), InterCloud Systems (ICLD), Plug Power (PLUG), PositiveID (PSID) and XTI Aerospace (XTIA).

Company Calendar

• Last Earnings: 8/20/2018
• Today: 7/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Nanotechnology
• Sub-Industry: Electrical Equipment
• Current Symbol: OTCMKTS:MHTX
• CIK: 1099132
• Web: www.mhtx.com
• Phone: (212) 541-2405
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $50 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 559,280,000
• Free Float: 493,286,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.33